CURLD
Curaleaf Holdings, Inc.
$10.52
-0.29 (-2.68%)
1 Down Day
Indicators
Price
Panels
Event markers
Price & Indicators
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.52
Open$10.80
Day$9.40–10.80
52W$0.80–12.45
Avg vol 30d451K
Short int472K · 1.0d
Short vol17%
DataJan 2020–Jul 2026
Equibles Rating
blended score
Overall
Neutral
Technical · trend & momentum
Buy
+
Price vs 200-day avg · +202% above
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+202% above
+
Price vs 50-day avg
+70% above
◦
RSI (14)
69 · neutral
−
MACD trend
negative
◦
52-week position
83% · mid-range
Sentiment · smart money
Bullish
+
Institutional flow · +6 funds added
◦
Trend (MA cross)
50d $6 › 200d $3 — 50d above 200d
+
Institutional flow
+6 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.08% of float · ▼ -66.6% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
6 holders — mid 3-yr range
Fundamentals
Weak
−
Revenue growth · −5% Y/Y
−
Revenue growth
−5% Y/Y
+
Gross margin
50%, expanding
−
EPS growth
−9% Y/Y
+
Free cash flow
$74.3M
−
Balance sheet
net debt $385.5M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Key facts
Market Cap
$7.44B
Shares
623,520,125
CIK
1756770
CUSIP
23126M102
Website
Visit website
Investor Relations
Investor relations
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+202% above
Bullish
Price vs 50-day avg
+70% above
Bullish
RSI (14)
69 · neutral
Neutral
MACD trend
negative
Bearish
52-week position
83% · mid-range
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $6 › 200d $3 — 50d above 200d
Institutional flow
Accumulating
+6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.08% of float · ▼ -66.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $11 · 83%
52-wk high $12
vs 200-day avg +202%
vs 50-day avg +70%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CURLD
this stock
Curaleaf Holdings, Inc.
|
$7.44B | +317.5% | -0.9% | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$53.33B | +9.7% | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$50.65B | +2.8% | — | — | 0.3% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$41.35B | -7.7% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CURLD | +12.8% | +193.0% | +324.2% | -2.7% | +317.5% |
| SPY | +1.8% | -1.6% | +7.9% | -1.3% | +9.5% |
| vs SPY | +11.0% | +194.6% | +316.3% | -1.4% | +308.0% |